hounslow consortium limited
hounslow consortium limited Company Information
Company Number
11080008
Next Accounts
Dec 2025
Shareholders
great west road healthcare limited
feltham & bedfont primary care network limited
View AllGroup Structure
View All
Industry
General medical practice activities
Registered Address
ramsay house, rbp, 18 vera avenue, london, N21 1RA
Website
-hounslow consortium limited Estimated Valuation
Pomanda estimates the enterprise value of HOUNSLOW CONSORTIUM LIMITED at £398.1k based on a Turnover of £724k and 0.55x industry multiple (adjusted for size and gross margin).
hounslow consortium limited Estimated Valuation
Pomanda estimates the enterprise value of HOUNSLOW CONSORTIUM LIMITED at £0 based on an EBITDA of £-168.9k and a 4.08x industry multiple (adjusted for size and gross margin).
hounslow consortium limited Estimated Valuation
Pomanda estimates the enterprise value of HOUNSLOW CONSORTIUM LIMITED at £0 based on Net Assets of £-142.4k and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hounslow Consortium Limited Overview
Hounslow Consortium Limited is a live company located in london, N21 1RA with a Companies House number of 11080008. It operates in the general medical practice activities sector, SIC Code 86210. Founded in November 2017, it's largest shareholder is great west road healthcare limited with a 20% stake. Hounslow Consortium Limited is a young, small sized company, Pomanda has estimated its turnover at £724k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Hounslow Consortium Limited Health Check
Pomanda's financial health check has awarded Hounslow Consortium Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 5 areas for improvement. Company Health Check FAQs
0 Strong
5 Regular
5 Weak
Size
annual sales of £724k, make it smaller than the average company (£2m)
- Hounslow Consortium Limited
£2m - Industry AVG
Growth
3 year (CAGR) sales growth of -66%, show it is growing at a slower rate (10.5%)
- Hounslow Consortium Limited
10.5% - Industry AVG
Production
with a gross margin of 39.9%, this company has a comparable cost of product (39.9%)
- Hounslow Consortium Limited
39.9% - Industry AVG
Profitability
an operating margin of -23.3% make it less profitable than the average company (3.7%)
- Hounslow Consortium Limited
3.7% - Industry AVG
Employees
with 9 employees, this is below the industry average (22)
- Hounslow Consortium Limited
22 - Industry AVG
Pay Structure
on an average salary of £34.6k, the company has an equivalent pay structure (£34.6k)
- Hounslow Consortium Limited
£34.6k - Industry AVG
Efficiency
resulting in sales per employee of £80.4k, this is equally as efficient (£88.5k)
- Hounslow Consortium Limited
£88.5k - Industry AVG
Debtor Days
it gets paid by customers after 30 days, this is near the average (30 days)
- Hounslow Consortium Limited
30 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Hounslow Consortium Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Hounslow Consortium Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 47 weeks, this is average cash available to meet short term requirements (39 weeks)
47 weeks - Hounslow Consortium Limited
39 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 106.2%, this is a higher level of debt than the average (56.3%)
106.2% - Hounslow Consortium Limited
56.3% - Industry AVG
HOUNSLOW CONSORTIUM LIMITED financials
Hounslow Consortium Limited's latest turnover from March 2024 is estimated at £724 thousand and the company has net assets of -£142.4 thousand. According to their latest financial statements, we estimate that Hounslow Consortium Limited has 9 employees and maintains cash reserves of £2.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 6 | |||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|---|
| Tangible Assets | ||||||
| Intangible Assets | ||||||
| Investments & Other | ||||||
| Debtors (Due After 1 year) | ||||||
| Total Fixed Assets | ||||||
| Stock & work in progress | ||||||
| Trade Debtors | 60,567 | 1,741,853 | 2,158,279 | 1,200,537 | ||
| Group Debtors | ||||||
| Misc Debtors | 17,911 | 17,911 | 17,911 | 223,368 | 1,705 | 96,331 |
| Cash | 2,207,958 | 2,827,863 | 2,230,341 | 474,074 | ||
| misc current assets | ||||||
| total current assets | 2,286,436 | 17,911 | 17,911 | 4,793,084 | 4,390,325 | 1,770,942 |
| total assets | 2,286,436 | 17,911 | 17,911 | 4,793,084 | 4,390,325 | 1,770,942 |
| Bank overdraft | ||||||
| Bank loan | ||||||
| Trade Creditors | 2,762,758 | 2,870,387 | 1,344,130 | |||
| Group/Directors Accounts | ||||||
| other short term finances | ||||||
| hp & lease commitments | ||||||
| other current liabilities | 2,428,855 | 49,387 | 49,387 | 2,105,779 | 1,443,597 | 373,460 |
| total current liabilities | 2,428,855 | 49,387 | 49,387 | 4,868,537 | 4,313,984 | 1,717,590 |
| loans | ||||||
| hp & lease commitments | ||||||
| Accruals and Deferred Income | ||||||
| other liabilities | ||||||
| provisions | ||||||
| total long term liabilities | ||||||
| total liabilities | 2,428,855 | 49,387 | 49,387 | 4,868,537 | 4,313,984 | 1,717,590 |
| net assets | -142,419 | -31,476 | -31,476 | -75,453 | 76,341 | 53,352 |
| total shareholders funds | -142,419 | -31,476 | -31,476 | -75,453 | 76,341 | 53,352 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | ||||||
| Amortisation | ||||||
| Tax | ||||||
| Stock | ||||||
| Debtors | 60,567 | -1,947,310 | -194,763 | 863,116 | 1,296,868 | |
| Creditors | -2,762,758 | -107,629 | 1,526,257 | 1,344,130 | ||
| Accruals and Deferred Income | 2,379,468 | -2,056,392 | 662,182 | 1,070,137 | 373,460 | |
| Deferred Taxes & Provisions | ||||||
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | ||||||
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | ||||||
| Group/Directors Accounts | ||||||
| Other Short Term Loans | ||||||
| Long term loans | ||||||
| Hire Purchase and Lease Commitments | ||||||
| other long term liabilities | ||||||
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 2,207,958 | -2,827,863 | 597,522 | 1,756,267 | 474,074 | |
| overdraft | ||||||
| change in cash | 2,207,958 | -2,827,863 | 597,522 | 1,756,267 | 474,074 |
hounslow consortium limited Credit Report and Business Information
Hounslow Consortium Limited Competitor Analysis
Perform a competitor analysis for hounslow consortium limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in N21 area or any other competitors across 12 key performance metrics.
hounslow consortium limited Ownership
HOUNSLOW CONSORTIUM LIMITED group structure
Hounslow Consortium Limited has no subsidiary companies.
Ultimate parent company
HOUNSLOW CONSORTIUM LIMITED
11080008
hounslow consortium limited directors
Hounslow Consortium Limited currently has 4 directors. The longest serving directors include Dr Chloe Hillman (Feb 2024) and Ms Lorraine Makin (Apr 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Chloe Hillman | England | 44 years | Feb 2024 | - | Director |
| Ms Lorraine Makin | England | 49 years | Apr 2024 | - | Director |
| Mrs Rosalyn King | United Kingdom | 52 years | Apr 2024 | - | Director |
| Dr Nittin Kumar | England | 43 years | Apr 2024 | - | Director |
P&L
March 2024turnover
724k
0%
operating profit
-168.9k
0%
gross margin
39.9%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
-142.4k
+3.52%
total assets
2.3m
+126.66%
cash
2.2m
0%
net assets
Total assets minus all liabilities
hounslow consortium limited company details
company number
11080008
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
November 2017
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
houslow consortium limited (February 2018)
accountant
-
auditor
-
address
ramsay house, rbp, 18 vera avenue, london, N21 1RA
Bank
-
Legal Advisor
-
hounslow consortium limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to hounslow consortium limited.
hounslow consortium limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HOUNSLOW CONSORTIUM LIMITED. This can take several minutes, an email will notify you when this has completed.
hounslow consortium limited Companies House Filings - See Documents
| date | description | view/download |
|---|
